Boothbay Fund Management
REVBW icon

Boothbay Fund Management’s Revelation Biosciences Warrant REVBW Stock Holding History

Boothbay Fund Management’s Portfolio REVBW Stock Details REVBW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-16,135
Closed -$163K – 2159
2021
Q3 		$163K Sell
16,135
-216,227
-93% -$131K ﹤0.01% 1642
2021
Q2 		$2.33M Sell
232,362
-3,160
-1% -$1.88K 0.08% 321
2021
Q1 		$2.35M Sell
235,522
-296,784
-56% -$277K 0.09% 268
2020
Q4 		$5.35M Buy
+532,306
New +$363K 0.2% 91

Other funds holding REVBW

Owl Creek Asset Management
Owl Creek Asset Management New York $1.21B AUM 169.99% 1-Year Est. Return
Linden Advisors
Linden Advisors New York $19.3B AUM 1.47% 1-Year Est. Return
CVI Holdings
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
Yakira Capital Management
Yakira Capital Management Westport, Connecticut $351M AUM 21.82% 1-Year Est. Return
Ionic Capital Management
Ionic Capital Management New York $690M AUM 70.34% 1-Year Est. Return
Rivernorth Capital Management
Rivernorth Capital Management West Palm Beach, Florida $2.1B AUM 2.15% 1-Year Est. Return
Empery Asset Management
Empery Asset Management New York $86.5M AUM
Polar Asset Management Partners
Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return
Capstone Investment Advisors
Capstone Investment Advisors New York $54B AUM 23.5% 1-Year Est. Return
TI
Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return

Boothbay Fund Management's REVBW Position: Q4 2021 in Review

Boothbay Fund Management sold out of Revelation Biosciences Warrant (REVBW) in Q4 2021, closing a stake of 16,135 shares — an estimated $163K sold.

Boothbay Fund Management first reported a position in REVBW in Q4 2020 and held it in 4 quarters. The position peaked at $5.35M in Q4 2020. 20 funds tracked by Wall St. Rank hold REVBW as of Q4 2021.

  • Boothbay Fund Management reported no remaining Revelation Biosciences Warrant position as of Q4 2021 after selling out during the quarter.
  • Boothbay Fund Management sold 16,135 Revelation Biosciences Warrant shares in Q4 2021, an estimated $163K.
  • Boothbay Fund Management first reported a position in Revelation Biosciences Warrant in Q4 2020 and held it in 4 quarters.
  • Boothbay Fund Management's Revelation Biosciences Warrant position peaked at $5.35M in Q4 2020.
  • 20 funds tracked by Wall St. Rank held Revelation Biosciences Warrant as of Q4 2021.

Based on Boothbay Fund Management's 13F filing for Q4 2021, filed 14 Feb 2022.